Copyright
©The Author(s) 2022.
World J Hepatol. Oct 27, 2022; 14(10): 1907-1919
Published online Oct 27, 2022. doi: 10.4254/wjh.v14.i10.1907
Published online Oct 27, 2022. doi: 10.4254/wjh.v14.i10.1907
Table 3 Comparison of patients with and without liver function test abnormalities
Variable | Alanine aminotransferase level (n = 161) | P value | ||
High (> 41 U/L), 14 (8.7) | Normal (≤ 41 U/L), 147 (91.3) | |||
Sex | Female | 9 (64.3) | 61(41.5) | 0.157a |
Male | 5 (35.7) | 86 (58.5) | ||
Nationality | Bahraini | 9 (64.3) | 104 (70.7) | 0.760a |
Non-Bahraini | 5 (35.7) | 43 (29.3) | ||
Gestational age (n = 135) | Term | 8 (57.1) | 98 (66.7) | 0.683 |
Preterm | 1 (7.1) | 28 (19.0) | ||
Age at presentation (mo), mean ± SD | 10.1 ± 12.8 | 10.6 ± 17.3 | 0.535b | |
Age at the time of study (mo), mean ± SD | 37.5 ± 13.2 | 37.8 ± 17.5 | 0.394b | |
Length of hospital stay (d), mean ± SD | 18.0 ± 19.3 | 13.4 ± 41.1 | 0.025b | |
History of fever | 9 (7.9) | 105 (92.1) | 0.552a | |
White blood cell count (× 109/L), mean ± SD | 12.2 ± 7.0 | 10.6 ± 5.3 | 0.764b | |
Hemoglobin (g/dL), mean ± SD | 11.6 ± 2.1 | 11.5 ± 2.4 | 0.796b | |
Platelet count (× 109/L), mean ± SD | 335.4 ± 194.8 | 417.6 ± 178.5 | 0.109b | |
Total serum protein (g/L), mean ± SD | 56.6 ± 7.3 | 57.9 ± 8.9 | 0.895b | |
Serum globulin (g/L), mean ± SD | 16.71 ± 3.69 | 18.1 ± 11.2 | 0.801b | |
Serum albumin (g/L), mean ± SD | 39.86 ± 5.89 | 41.63 ± 11.1 | 0.971b | |
Total bilirubin (µmol/L), mean ± SD | 29.4 ± 41.2 | 38.11 ± 62.81 | 0.794b | |
Direct bilirubin (µmol/L), (n = 71), mean ± SD | 24.1 ± 39.9 | 10.5 ± 5.7 | 0.722b | |
Indirect bilirubin (µmol/L), (n = 71), mean ± SD | 22.5 ± 17.9 | 62.0 ± 75.1 | 0.184b | |
Alkaline phosphatase (U/L), mean ± SD | 271.9 ± 217.2 | 239.9 ± 133.1 | 0.935b | |
Gamma-glutamyl transferase (U/L), (n = 145), mean ± SD | 92.4 ± 88.2 | 60.6 ± 79.0 | 0.080b | |
Prothrombin time, (n = 46), mean ± SD | 13.2 ± 1.6 | 13.8 ± 3.0 | 0.809b | |
INR, (n = 46), mean ± SD | 1.1 ± 0.1 | 1.2 ± 0.3 | 0.831b | |
PTT, (n = 46), mean ± SD | 25.5 ± 4.9 | 28.8 ± 10.4 | 0.579b | |
Fibrinogen, (n = 34), mean ± SD | 326.4 ± 387.2 | 277.3 ± 166.4 | 0.581b | |
Thrombin time, (n = 33), mean ± SD | 21.4 ± 7.3 | 16.9 ± 2.0 | 0.131b | |
Random blood glucose, (n = 52), mean ± SD | 6.0 ± 1.0 | 6.0 ± 1.0 | 0.905b | |
Positive blood culture (n = 127) | 2 (14.3) | 10 (6.8) | 0.278a | |
Positive urine culture (n = 88) | 3 (21.4) | 4 (2.7) | 0.030a | |
Positive cerebrospinal fluid culture (n = 23) | 0 (0.0) | 1.0 (0.7) | 1.000a | |
Positive RSV test (n = 159) | 6 (42.9) | 46 (31.3) | 0.356a | |
Antibiotic use (n = 157) | 11 (78.6) | 115 (78.2) | 1.000a | |
Complications | 2 (14.3) | 28 (19) | 1.000a | |
Admission to the intensive care unit | 1 (7.1) | 10 (6.8) | 1.000a | |
Mortality | 1 (7.1) | 8 (5.4) | 0.569a |
- Citation: Isa HM, Hasan AZ, Khalifa SI, Alhewaizem SS, Mahroofi AD, Alkhan FN, Al-Beltagi M. Hepatic involvement in children with acute bronchiolitis. World J Hepatol 2022; 14(10): 1907-1919
- URL: https://www.wjgnet.com/1948-5182/full/v14/i10/1907.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i10.1907